The company reported total revenues of C$60.1 million, down 11% year over year but up 10% quarter over quarter.
A number of analysts changed their 12-month price targets on Aurora Cannabis after the results, bringing the average to C$7.73, or a 17% downside to the stock.
For the results, Aurora came in slightly below Canaccord’s C$62.24 million revenue estimate.
Lastly, Canaccord says that Aurora boasts a healthy balance sheet with them raising C$666 million last fiscal year, increasing their share count by 63%.
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions.